← Eichor
Condition: Utuc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Utuc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · 62 location(s) · UroGen Pharma Ltd. · NCT06774131Liquid Biospy for Urinary Cancers
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06116396Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06598761A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05438537Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Phase 1/Phase 2 · 9 location(s) · Ferring Pharmaceuticals · NCT06668493Radical Radiotherapy Versus Radical Surgery for UTUC
Phase N/A · 2 location(s) · Peking University First Hospital · NCT06652009Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma
NA · 1 location(s) · Tianjin Medical University Second Hospital · NCT07321210uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Phase N/A · 22 location(s) · UroGen Pharma Ltd. · NCT05874921DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
Phase 2 · 1 location(s) · Fudan University · NCT06354231Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
Phase 2 · 1 location(s) · RenJi Hospital · NCT05912816Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT07126119POST URS Chemotherapy Instillation
NA · 10 location(s) · Carmel Medical Center · NCT06167057Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-
Phase 2 · 1 location(s) · Tianjin Medical University Second Hospital · NCT05837806Urine Methylation Markers in UTUC
NA · 1 location(s) · Duke University · NCT06805630An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With
Phase 3 · 160 location(s) · AstraZeneca · NCT07720284Renal Retention in High Grade Upper Tract Urothelial Cancer
Phase 2 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT05656235A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treat
Phase 2 · 1 location(s) · Peking University First Hospital · NCT06210490Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
Phase 3 · 2 location(s) · University Health Network, Toronto · NCT04574960Ambulatory Flexible URS for UTUC Surveillance
Phase 1 · 2 location(s) · Chinese University of Hong Kong · NCT06848868Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper
Phase N/A · 1 location(s) · RenJi Hospital · NCT05595408A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Mi
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06991868The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
Phase N/A · 5 location(s) · Zealand University Hospital · NCT07077447Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
Phase N/A · 1 location(s) · Henan Provincial People's Hospital · NCT07614594Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Phase N/A · 3 location(s) · Peking University First Hospital · NCT06120374A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
Phase 2 · 1 location(s) · Jinling Hospital, China · NCT05917158Effect of a SI-MMC on the IVR Rate After Ureteroscopy for UTUC
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05731622Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NA · 1 location(s) · National Taiwan University Hospital · NCT06987552Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Phase 2 · 15 location(s) · Tyra Biosciences, Inc · NCT07265947Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
Phase 2 · 1 location(s) · Samsung Medical Center · NCT07225374
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.